Bavarian Nordic drops most cancers vaccine efforts to concentrate on infectious sicknesses
Bavarian Nordic will not paintings on its immuno-oncology vaccine professionalgram to instead focus on infectious disease R&D, with the compathe big apple’s “document” 2023 gross sales buoyed via its mpox vaccine Jynneos.
